BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15195755)

  • 1. Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.
    Fukumoto M
    Ann Nucl Med; 2004 Apr; 18(2):79-95. PubMed ID: 15195755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.
    Choi JY; Kim SE; Shin HJ; Kim BT; Kim JH
    J Neurooncol; 2000; 46(1):63-70. PubMed ID: 10896206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
    Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
    J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
    Gremillet E; Champailler A
    Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
    Hashimoto T; Goto K; Hishinuma Y; Yachuda K; Sugioka Y; Arai K; Harada S; Goto M
    Ann Nucl Med; 2000 Aug; 14(4):293-8. PubMed ID: 11023030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
    Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
    Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behaviors of cost functions in image registration between 201Tl brain tumor single-photon emission computed tomography and magnetic resonance images.
    Soma T; Takaki A; Teraoka S; Ishikawa Y; Murase K; Koizumi K
    Ann Nucl Med; 2008 Nov; 22(9):825-32. PubMed ID: 19039563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the response to cardiac resynchronization therapy using 99mTc-tetrofosmin myocardial scintigraphy in patients with drug-refractory heart failure: additional value of the washout of 99mTc-tetrofosmin.
    Shigeru M; Fujiwara S; Takamine S; Yoshida A; Kawai H; Shiotani H; Hirata K
    Nucl Med Commun; 2014 Sep; 35(9):939-46. PubMed ID: 24977350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
    Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S
    Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: MRI validation and comparison of the Emory Cardiac Tool Box with QGS and 4D-MSPECT.
    Schaefer WM; Lipke CS; Standke D; Kühl HP; Nowak B; Kaiser HJ; Koch KC; Buell U
    J Nucl Med; 2005 Aug; 46(8):1256-63. PubMed ID: 16085580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
    Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
    Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
    Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
    Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion.
    Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P
    J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
    Arbab AS; Koizumi K; Toyama K; Araki T
    J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [99mTc-MIBI scintigraphy of hypofunctional thyroid nodules. Comparison of planar and SPECT imaging].
    Schenke S; Zimny M; Rink T; Stahl U; Fritzel M; Klett R
    Nuklearmedizin; 2014; 53(3):105-10. PubMed ID: 24510009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve.
    Pirich C; Keinrath P; Rettenbacher L; Rendl G; Holzmannhofer J; Hammerer M; Schuler J; Beheshti M
    Nuklearmedizin; 2014; 53(3):111-6. PubMed ID: 24963973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.